论文部分内容阅读
急性髓细胞白血病(acute myeloocytic leukemia,AML)核心结合因子包括t(8;21)(q22;q22)和inv(16)(p13q22)/t(16;16)(p13;q22)两大类,其中inv(16)在临床上被认为是较好的细胞遗传学分型标准。许多小样本的研究报道,t(8;21)型AML患者行造血干细胞移植(hematopoietic stemcell tra
The core binding factors of acute myelocytic leukemia (AML) include two major categories of t (8; 21) (q22; q22) and inv (16) (p13q22) / t Which inv (16) is clinically considered a better cytogenetic typing criteria. Many small sample studies have reported that t (8; 21) AML patients underwent hematopoietic stem cell transplantation